Antiangiogenic Agents: Studies on Fumagillin and Curcumin Analogs

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|11|3|357-373

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.3, 2005-02, pp. : 357-373

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lesson Learned from Nature for the Development of Novel Anti-Cancer Agents: Implication of Isoflavone, Curcumin, and their Synthetic Analogs

By  

Current Pharmaceutical Design, Vol. 16, Iss. 16, 2010-06 ,pp. : 1801-1812

Bentham Science Publishers

Access to resources Recommend Favorite

Synthetic Curcumin Analogs as Inhibitors of β -Amyloid Peptide Aggregation: Potential Therapeutic and Diagnostic Agents for Alzheimer's Disease

By  

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 13, 2015-09 ,pp. : 1110-1121

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological and Clinical Studies on Purine Nucleoside Analogs- New Anticancer Agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 5, 2006-05 ,pp. : 575-581

Bentham Science Publishers

Access to resources Recommend Favorite

Antiangiogenic agents for the treatment of glioblastoma

By Gerstner Elizabeth R   Duda Dan G   Tomaso Emmanuelle di   Sorensen Greg   Jain Rakesh K   Batchelor Tracy T  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 12, 2007-12 ,pp. : 1895-1908

Informa Healthcare

Access to resources Recommend Favorite

Antiangiogenic Effect of Curcumin in Pure Versus in Extract Forms

By Liu Dong   Schwimer Joshua   Liu Zhijun   Woltering Eugene   Greenway Frank  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 46, Iss. 10-11, 2008-10 ,pp. : 677-682

Informa Healthcare

Access to resources Recommend Favorite